A Prospective Study to Detect Immune Checkpoint Inhibitors Associated With Myocarditis Among Patients Treated for Lung Cancer

医学 心肌炎 内科学 肺癌 心脏病学 癌症 不利影响
作者
Clara Faubry,Maxime Faure,Anne-Claire Toublanc,Rémi Veillon,Anne-Iris Lemaître,Charlotte Vergnenègre,Hubert Cochet,Sadia Khan,Chantal Rahérison,Pierre Dos Santos,M. Zysman
出处
期刊:Frontiers in Cardiovascular Medicine [Frontiers Media]
卷期号:9 被引量:12
标识
DOI:10.3389/fcvm.2022.878211
摘要

Background Immune checkpoint inhibitors (ICIs) are widely used in lung cancer management. However, myocarditis, which is a rare, yet potentially severe adverse-related event associated with ICIs, could be under-reported. Objectives This study is aimed to prospectively evaluate the cumulative incidence rate of myocarditis, through systematic screening, among patients receiving ICIs for lung cancer. Methods All patients who received the first administration of ICIs for non-small cell (NSCLC) and small cell lung cancer (SCLC), between May and November 2020, in the pulmonary department of Bordeaux University Hospital, were included. Echocardiography (ECG), troponin-I, and natriuretic peptide dosages before ICIs' first administration and before each infusion were recorded. ECG and magnetic resonance imaging (MRI) were done additionally, in case of at least three times increase in troponin levels, ECG modifications, and the onset of cardiovascular symptoms. Second, if possible, coronarography than endomyocardial biopsy was assessed. The primary outcome was defined as ICIs related to myocarditis onset, while secondary outcomes included other cardiovascular events, disease-free, and overall survival. Results During the period of interest, 99 patients received their first infusion of ICIs for lung cancer (mean age 64 ± 9 years; 52 men, 67% with adenocarcinoma). Three cases of myocarditis without major adverse cardiac events (MACEs) occurred (two definite and one possible), and the mean duration between the first ICIs' administration and myocarditis onset was 144 ± 3 days. Median disease-free survival and overall survival were 169 [102; 233] days and 209 [147; 249] days, respectively. Conclusion In our study, systematic screening of myocarditis associated with ICIs leads to a more frequent incidence and a later onset than previously reported. None of them were severe. Additional prospective evidence is needed before we could adopt routine cardiac screening in unselected patients starting ICIs; however, these data shed new light on the risk of myocarditis associated with ICIs administration.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kiiso发布了新的文献求助10
1秒前
1秒前
江枫渔火完成签到 ,获得积分0
2秒前
tang发布了新的文献求助10
2秒前
Juvenilesy的应助被墨尘采纳,获得10
2秒前
pmh完成签到,获得积分10
4秒前
和谐完成签到 ,获得积分10
4秒前
D_DAY完成签到,获得积分10
5秒前
6秒前
6秒前
6秒前
hudirudi完成签到,获得积分10
8秒前
神经蛙完成签到,获得积分10
8秒前
学术小白完成签到,获得积分10
8秒前
9秒前
kiterunner发布了新的文献求助10
10秒前
Hao完成签到 ,获得积分10
10秒前
misong完成签到,获得积分10
11秒前
yyn完成签到,获得积分10
12秒前
酷波er的应助被Ronin采纳,获得10
12秒前
12秒前
英姑的应助被qingtong采纳,获得10
12秒前
微笑的语梦完成签到 ,获得积分10
14秒前
akilli完成签到 ,获得积分10
14秒前
CipherSage的应助被墩子采纳,获得10
15秒前
15秒前
CAOHOU的应助被吱吱采纳,获得10
17秒前
17秒前
19秒前
21秒前
drleslie完成签到 ,获得积分10
22秒前
Alexlovar发布了新的文献求助30
23秒前
23秒前
凯旋归来完成签到 ,获得积分10
23秒前
23秒前
24秒前
zhanzhanzhan发布了新的文献求助20
24秒前
25秒前
路小雨发布了新的文献求助10
26秒前
蒋莹萱完成签到 ,获得积分10
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621